FDA Approves 1st COVID-19 Shot For Kids: US
The United States Food and Drug Administration (FDA) has approved Pfizer, and BioNTech SE Coronavirus vaccines for children aged between 5 to 11 years. Reports stated that the FDA's decision is expected to make vaccines available to 28 million American children going to school. As of now, Only a few countries such as China, Cuba and United Arab Emirates have so far cleared vaccines for children, said reports.
Tags: covid 19, coronavirus treatment, Pfizer-BioNTech Vaccine, United States, children
Courtesy: Reuters
American Pharma Pauses Trials of Potential COVID-19 Treatment
American Pharmaceutical company, Eli Lilly, which was running trials of a potential "antibody treatment" for COVID-19 has paused its trials. Reportedly, the trials were approved by the US Government and the treatment was based on the use of "monoclonal antibodies". Reports suggest that the trial was paused owing to "potential safety concerns". Though the company confirmed the news, it did not reveal the exact cause.
Tags: Eli Lilly, antibody, Covid-19, coronavirus treatment, United States
Courtesy: The Economic Times
Chennai: Non-COVID Hospitals Cannot Deny 'Lifesaving' Treatment
The Tamil Nadu government has directed the non-COVID hospitals to reserve beds to treat COVID patients, in emergency conditions, after receiving complaints regarding denial of emergency treatment to COVID patients. The director of medical and rural health services stressed that the patients should be given “health measures to stabilize and preserve life,” before referring to a COVID hospital. The director also warned the hospitals of legal… read-more
Tags: Chennai, Tamil Nadu, Covid-19, Private Hospitals, coronavirus treatment
Courtesy: The Economic Times
Adding Umifenovir Doesn't Enhance Efficacy Of Favipiravir Drug Regimen
Adding antiviral Umifenovir in Favipiravir drug regimen does not enhance the effectiveness of the latter, asserted Glenmark Pharmaceuticals on October 9. Reportedly, the pharmaceutical company had conducted clinical trials to determine the efficacy of addition of Umifenovir against mono-therapy of Favipiravir tablets. Earlier, Glenmark had conducted clinical trials to determine the use of Favipiravir for COVID-19 treatment and had eventually… read-more
Tags: glenmark pharmaceuticals, Covid-19, coronavirus treatment, Favipiravir
Courtesy: The Economic Times
US President Trump Discharged From Hospital; To Begin Campaigning Soon
US President Donald Trump, after a four-day stay for COVID-19 treatment, was discharged from the Walter Reed Medical Centre on October 5 . Dr Sean Coley said the President's health had improved, and he had met or exceeded all standard hospital discharge criteria. While leaving the hospital, Trump tweeted, "Will be back on the Campaign Trail soon!" However, doctors said Trump will remain under medical supervision for next few days.
Tags: Donald Trump, Covid-19, coronavirus treatment, United States
Courtesy: Hindustan Times
ICMR Develops A Potential Cure For COVID-19
Indian Council of Medical Research (ICMR), on October 1, announced that it has developed a potential drug for curing COVID-19, in collaboration with Biological E Limited. ICMR said that it has prepared a "highly purified antisera", which is supposedly acquired from horses, after infecting them with inactivated Sars-CoV2. ICMR added that the "antisera" will have to undergo clinical trials, to establish safety and efficacy.
Tags: ICMR, Covid-19, drug, coronavirus treatment
Courtesy: The Economic Times
Russia Approves First Prescription Drug To Treat Mild and Moderate COVID-19 Symptoms
In a bid to control COVID-19, Russia has authorized R-Pharm's 'Coronavir' as a prescription drug for the treatment of Coronavirus. Reportedly, the drug can be used to treat COVID-19 patients with mild and moderate symptoms and the company is planning to make it available in pharmacies by next week. Russia is the first nation to have approved a prescription drug for Coronavirus.
Tags: Coronavirus, coronavirus treatment, Pharmacy, COVID-19 DRUG
Courtesy: The Economic Times
Kochi-based Pharma Gets Approval to Start Phase-2 Trials for COVID-19 Drug
Central Licensing Authority, under the Central Drugs Standard Control Organization, has granted approval to Kochi-based pharma, PNB Vesper to begin phase-2 trials of a COVID-19 drug. The drug, 'PNB001', which is a new chemical entity (one that contains molecules which have never been approved by USFDA), is the first-of-its-kind to start phase-2 trials. According to… read-more
Tags: Covid-19, Coronavirus, coronavirus treatment, Kochi, Indian Pharma
Courtesy: The Economic Times